Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs

Table 2 Clinical translation of myeloid suppressor cell therapy in solid organ transplantation

	Origin	Time	Pre-clinical	Clinical	Ref.
M reg	Donor	Pre-	Mouse, pig, dog	TAIC- I, TAIC-II, The ONE Study	[1–3, 6, 16, 56–58]
Tol-DC	Recipient	Peri-/post-	Rat, NHP	The ONE Study	[6, 18, 20, 53, 54]
DC-10	Recipient/Donor DC10 + recipient Tr-1	Peri-/post-	Rat	-	[59]
Rapa-DC	Donor-pulsed recipient	Pre-Post	Mouse	-	[25]
MDSC	Recipient	Peri-/Post-	Mouse	-	[60]

ISSN: 2047-1440